Last update: 20/06/21 Connect with us:

Because of the corona situation we decided to postpone the meeting to 2022
The 8th European Workshop on Lipid Mediators will be held on
June 29th - July 1st, 2022
It will be a face to face congress with real coffee breaks, sponsor stands, gala dinner and real speakers!

Welcome

Scientific Program

Junior Session &
Travel Award

Registration & Abstract Submission

All the sponsors

Venue Photos-Map

Travel Informationn

Hotel Reservation

Committees and Contact

Past-Workshops on Lipid Mediators

 


Program

PROGRAM (in progress, timing will be posted soon)

8th European Workshop on Lipid Mediators (8EWLM)
‘A Marcus Wallenberg symposium’

Karolinska Institute, Stockholm, Sweden
June 29th - July1st, 2022

Wednesday, June 29th

Educational SESSION

Opening address by organizers

Chengcan Yao
“An update of PGE2’s roles in mucosal inflammation”

Cécile Gladine  
"Inter-individual variability of the circulating oxylipin profiles in humans: major determinants and consequences in clinical research"

Craig Wheelock 
Title TBA

1st Sponsored SESSION
PGI2  analogues from bench to bedside

Lucie Clapp   (University College London, UK)
"Multiple cellular targets for prostacyclin (IP) receptor agonists; therapeutic implications in pulmonary hypertension"

Olivier Sitbon   (AP-HP, Hôpital de Bicêtre - Université Paris-Sud, France)
"Therapeutic use of prostacyclin in pulmonary hypertension"

1 talk selected  from the submitted abstracts
1 talk selected  from the submitted abstracts

2nd Sponsored SESSION
Resolution of Inflammation

Opening lecture of the sponsored Session about Resolution
Charles Serhan  
(Brigham and Women's Hospital-Harvard Medical School, Boston, US)
“Pro-resolving lipid mediators are novel signals for tissue regeneration"

Marc Dubourdeau (Ambiotis SAS, Toulouse, France)
“Resolution lipid signature in different physiological and pathological contexts”

1 talk selected  from the submitted abstracts
1 talk selected  from the submitted abstracts

Thursday, June 30th

Welcome and Morning address by organizers

Opening Plenary Lecture
Bengt Samuelsson   Nobel Prize Laureate, Karolinska Institutet, Sweden)
From Early Discoveries to New Drugs

SESSION 1. - Lipid mediator research at the Karolinska Institute
Chairman: Olof Rådmark

Jesper Z. Haeggström
The leukotriene cascade, molecular mechanisms and therapeutic opportunities

Magnus Bäck
Receptors for pro-resolving mediators in atherosclerosis


Sven-Erik Dahlén   – Lipid mediators in asthma and NSAID intolerance
Johan Kolmert   – Molecular phenotyping of asthma using urinary eicosanoid biomarkers
Per-Johan Jakobsson & Charlotte Edenius   – mPGES-1 background and phase I trial

Karin Larsson   – mPGES-1 in cancer
Eric Herlenius   - Inflammation, apnea and inspiration
Jenny Mjösberg   – Lipid mediator regulation of ILC2 cells
Craig Wheelock   – Novel linoleic acid mediators

SESSION 2. 10-00 -12.00 – Enzymatic formation, receptors and signal transduction
Chairperson: TBA

Oliver Werz   (Friedrich-Schiller-University Jena, Germany)
Natural products that promote the lipid mediator class switch in inflammation

Takao Shimizu   (University of Tokyo, Japan)
Roles of PUFAs in vivo: from mediators to membrane

3 speakers selected from abstracts

SESSION 3. – Lipid mediator classes and structural chemistry
Chairperson: TBA

Joost CM Holthuis   (University of Osnabrück, Germany)
Molecular dissection of ceramide-induced apoptosis using light-driven lipid probes

Trond Vidar Hansen   (University of Oslo, Norway)
Elucidation of the biosynthetic pathways of the protectins

3 speakers selected from abstracts 

Friday July 1st

Plenary lecture
Garret A. FitzGerald
  (University of Pennsylvania, USA) (30 min + 10 min Q&A)
Cyclooxygenases; their products and inhibitors

SESSION 4. Lipid mediators in disease and therapeutic approaches – I
Chairperson: TBA

Catherine Godson (University College Dublin, Ireland)
New tools in Resolving Inflammation and Suppressing Fibrosis

Hanns-Ulrich Marschall (Sahlgrenska Academy, University of Gothenburg, Sweden)
Bile acid metabolism and FXR-mediated effects

 3 speakers selected from abstracts

Young Investigator Session

10 Young scientist speakers selected from abstracts

SESSION 5. Lipid mediators in disease and therapeutic approaches – II
Chairperson: TBA

Bruce D Levy   (Brigham and Women's Hospital and Harvard Medical School, USA)
Towards Targeting Pro-Resolution Pathways of Inflammation in Airway Disease

Mauro Perretti   (Queen Mary University of London, UK)
Pro-resolving lipid mediators and the control of arthritis

3 speakers selected from abstracts 

Adjourn: Workshop closing address by organizers.

 

 

 






The Special Issue of
our previous European
Workshop on Lipid
Mediators (Brussels Edition)
is now on-line

 

Our Sponsors:

 

Our Sponsors: